L-thyroxine(T4)
From DrugPedia: A Wikipedia for Drug discovery
Pubchem(5819) The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
Lipinski’s “Rule of Five” Prediction for a Compound’s ABSORPTION OR PERMEABILITY PROPERTIES.
4 | 3 | 2 | 1 | 0 |
---|---|---|---|---|
GOOD | INDETERMINATE | INDETERMINATE | INDETERMINATE | POOR |
KEGG Pathway(C01829) Tyrosine metabolism Neuroactive ligand-receptor interaction Autoimmune thyroid disease Comment Thyroid hormone synthesized on thyroglobulin
MMDB ID | PDB ID | Reference |
---|---|---|
18746 | 1ICT | Wojtczak A, Luft JR, Cody VStructural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complexJ. Biol. Chem. v268, p.6202-6206
The crystal structure of human transthyretin (TTR) complexed with milrinone (2-methyl-5-cyano-3,4"-bipyridin-6(1H)-one), a positive inotropic cardiac agent, has been refined to R = 17.4% for 8-1.9-A resolution data. This report provides the first detailed description of protein interactions for an inotropic bipyridine agent which is an effective thyroid hormone binding competitor to transthyretin.... |
19209 | 1IE4 | Wojtczak ACrystal structure of rat transthyretin at 2.5 A resolution: first report on a unique tetrameric structureActa Biochim. Pol. v44, p.505-517
The first observation of a unique tetrameric molecular structure of transthyretin from rat (rTTR, prealbumin) is reported. The structure has been determined by X-ray diffraction using molecular replacement and the structure of human transthyretin (hTTR) as a starting model. Crystals of native rat transthyretin are tetragonal, space group P4(3)2(1)2, and have four independent monomers in the asymmetric unit of the crystal lattice.... |
22897 | 1HK1 | |
22898 | 1HK2 | |
22893 | 1HK3 | |
22900 | 1HK4 | |
22901 | 1HK5 | Petitpas I, Petersen CE, Ha CE, Bhattacharya AA, Zunszain PA, Ghuman J, Bhagavan NV, Curry SStructural basis of albumin-thyroxine interactions and familial dysalbuminemic hyperthyroxinemiaProc. Natl. Acad. Sci. U. S. A. v100, p.6440-6445
Human serum albumin (HSA) is the major protein component of blood plasma and serves as a transporter for thyroxine and other hydrophobic compounds such as fatty acids and bilirubin. We report here a structural characterization of HSA-thyroxine interactions. Using crystallographic analyses we have identified four binding sites for thyroxine on HSA distributed in subdomains IIA, IIIA, and IIIB.... |
28581 | 1SN0 | Eneqvist T, Lundberg E, Karlsson A, Huang S, Santos CR, Power DM, Sauer-Eriksson AEHigh resolution crystal structures of piscine transthyretin reveal different binding modes for triiodothyronine and thyroxineJ. Biol. Chem. v279, p.26411-26416
Transthyretin (TTR) is an extracellular transport protein involved in the distribution of thyroid hormones and vitamin A. So far, TTR has only been found in vertebrates, of which piscine TTR displays the lowest sequence identity with human TTR (47%). Human and piscine TTR bind both thyroid hormones 3,5,3"-triiodo-l-thyronine (T(3)) and 3,5,3",5"-tetraiodo-l-thyronine (thyroxine, T(4)).... |
3173 | 1Y0X | Sandler B, Webb P, Apriletti JW, Huber BR, Togashi M, Cunha Lima ST, Juric S, Nilsson S, Wagner R, Fletterick RJ, Baxter JDThyroxine-thyroid hormone receptor interactionsJ. Biol. Chem. v279, p.55801-55808
Thyroid hormone (TH) actions are mediated by nuclear receptors (TRs alpha and beta) that bind triiodothyronine (T(3), 3,5,3"-triiodo-l-thyronine) with high affinity, and its precursor thyroxine (T(4), 3,5,3",5"-tetraiodo-l-thyronine) with lower affinity. T(4) contains a bulky 5" iodine group absent from T(3). Because T(3) is buried in the core of the ligand binding domain (LBD), we have predicted that TH analogues with 5" substituents should fit poorly into the ligand binding pocket and perhaps behave as antagonists.... |
5764 | 2CEO | Zhou A, Wei Z, Read RJ, Carrell RWStructural mechanism for the carriage and release of thyroxine in the bloodProc. Natl. Acad. Sci. U. S. A. v103, p.13321-13326
The hormones that most directly control tissue activities in health and disease are delivered by two noninhibitory members of the serpin family of protease inhibitors, thyroxine-binding globulin (TBG) and corticosteroid-binding globulin. The structure of TBG bound to tetra-iodo thyroxine, solved here at 2.8 A, shows how the thyroxine is carried in a surface pocket on the molecule.... |
5764 | 2ROX | Wojtczak A, Luft JR, Cody VStructural aspects of inotropic bipyridine binding. Crystal structure determination to 1.9 A of the human serum transthyretin-milrinone complexJ. Biol. Chem. v268, p.6202-6206
The crystal structure of human transthyretin (TTR) complexed with milrinone (2-methyl-5-cyano-3,4"-bipyridin-6(1H)-one), a positive inotropic cardiac agent, has been refined to R = 17.4% for 8-1.9-A resolution data. This report provides the first detailed description of protein interactions for an inotropic bipyridine agent which is an effective thyroid hormone binding competitor to transthyretin.... |
67282 | 2RIW | Description The Reactive Loop Cleaved Human Thyroxine Binding Globulin Complexed With Thyroxine.
Deposition: Zhou A, Wei Z, Stanley PLD, Read RJ, Stein PE, Carrell RW, 2007/10/12 |
898 | 1ETA | Hamilton JA, Steinrauf LK, Braden BC, Liepnieks J, Benson MD, Holmgren G, Sandgren O, Steen LThe x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolutionJ. Biol. Chem. v268, p.2416-2424
The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-A resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (Fobs > 2.0 sigma). Standard deviations for stereochemical parameters are 0.018 and 0.022 A for bond distances, 0.030 and 0.038 A for angle distances, and 0.035 and 0.070 A for planar 1-4 distances.... |
899 | 1ETB | Hamilton JA, Steinrauf LK, Braden BC, Liepnieks J, Benson MD, Holmgren G, Sandgren O, Steen LThe x-ray crystal structure refinements of normal human transthyretin and the amyloidogenic Val-30-->Met variant to 1.7-A resolutionJ. Biol. Chem. v268, p.2416-2424
The x-ray crystal structures of normal human transthyretin (prealbumin) and the amyloidogenic Val-30-Met variant have been refined at 1.7-A resolution to R-values of 0.168 and 0.179, respectively, for 19,882 and 20,362 reflections (Fobs > 2.0 sigma). Standard deviations for stereochemical parameters are 0.018 and 0.022 A for bond distances, 0.030 and 0.038 A for angle distances, and 0.035 and 0.070 A for planar 1-4 distances.... |
Physical Property | Value | Units | Temp (deg C) | Source |
---|---|---|---|---|
Melting Point | 235.5 | deg C | EXP | |
log P (octanol-water) | 4.120 | (none) | EST | |
Water Solubility | 1.05E-04 | mg/L | 25 | EST |
Vapor Pressure | 1.24E-17 | mm Hg | 25 | EST |
7.91E-19 | atm-m3/mole | 25 | EST | |
Atmospheric OH Rate Constant | 4.17E-11 | cm3/molecule-sec | 25 | EST |
Organism | Test Type | Route | Reported Dose (Normalized Dose) | Effect | Source |
---|---|---|---|---|---|
child | TDLo | oral | 328ug/kg (0.328mg/kg) | CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP,VASCULAR: BP LOWERING NOT CHARACTERIZED IN AUTONOMIC SECTION | Pediatrics. Vol. 73, Pg. 313, 1984.Link to PubMed |
man | TDLo | oral | 63ug/kg (0.063mg/kg) | PTIONS",CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP | Journal of Toxicology, Clinical Toxicology. Vol. 20, Pg. 517, 1983.,Link to PubMed |
man | TDLo | oral | 10286ug/kg (10.286mg/kg) | BEHAVIORAL: EXCITEMENT,CARDIAC: PULSE RATE INCREASE WITHOUT FALL IN BP,
GASTROINTESTINAL: NAUSEA OR VOMITING | Veterinary and Human Toxicology. Vol. 41, Pg. 323, 1999.Link to PubMed |
women | TDLo | oral | 400ug/kg/2D-I (0.4mg/kg) | BEHAVIORAL: COMA,CARDIAC: ARRHYTHMIAS (INCLUDING CHANGES IN CONDUCTION) | Intensive Care Medicine. Vol. 13, Pg. 33, 1987.Link to PubMed |